These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2743268)

  • 1. Delayed erosion of intraperitoneal chemotherapy catheters into the bowel. Report of two cases.
    Varney RR; Goel R; vanSonnenberg E; Lucas WE; Casola G
    Cancer; 1989 Aug; 64(3):762-4. PubMed ID: 2743268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
    Emerich J; Milczek T; Debniak J; Majdak E
    Ginekol Pol; 2002 Nov; 73(11):1103-8. PubMed ID: 12722406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of protrusion of an intraperitoneal chemotherapy catheter through rectum.
    Bilsel Y; Balik E; Bugra D; Yamaner S; Akyuz A
    Int J Gynecol Cancer; 2005; 15(1):171-4. PubMed ID: 15670314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
    Milczek T; Emerich J; Klasa-Mazurkiewicz D
    Ginekol Pol; 2003 Sep; 74(9):817-23. PubMed ID: 14674130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Walker JL; Armstrong DK; Huang HQ; Fowler J; Webster K; Burger RA; Clarke-Pearson D
    Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ports and complications for intraperitoneal chemotherapy delivery.
    Helm CW
    BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal chemotherapy complicated by erosion of a Tenckhoff catheter into the colon.
    Holt RW; Petrilli ES; Evans SR; Ahlgren JD
    South Med J; 1989 Jul; 82(7):914-6. PubMed ID: 2749364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula.
    Ghosh K; Geller MA; Twiggs LB
    Gynecol Oncol; 2000 May; 77(2):327-9. PubMed ID: 10785489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
    Lesnock JL; Richard SD; Zorn KK; Krivak TC; Beriwal S; Sukumvanich P; McBee WC; Kelley JL; Edwards RP
    Gynecol Oncol; 2010 Mar; 116(3):345-50. PubMed ID: 19959211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.
    Ye M; Pan HM; Wang HY; Lou F; Jin W; Zheng Y; Wu JM
    World J Gastroenterol; 2004 May; 10(9):1372-4. PubMed ID: 15112363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functioning of implantable catheters of intraperitoneal chemotherapy].
    de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapy.
    Nguyen HN; Averette HE; Wyble L; Sevin BU; Donato D; Penalver M
    J Surg Oncol; 1993 Apr; 52(4):237-40. PubMed ID: 8468986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.
    Bryant CS; Shah JP; Triest JA; Schimp VL; Morris RT
    Gynecol Oncol; 2008 Dec; 111(3):552-4. PubMed ID: 18289650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
    de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
    Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of complications associated with catheter intraperitoneal chemotherapy of ovarian carcinoma].
    Wei LH; Qian HN; Li WF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):732-4, 762-3. PubMed ID: 7712902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
    Topuz E; Salihoglu Y; Aydiner A; Saip P; Tas F; Sozen T; Berkman S; Bengisu E
    J Surg Oncol; 2000 Jul; 74(3):223-6. PubMed ID: 10951423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.